Stock LCTX LINEAGE CELL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Lineage Cell Therapeutics, Inc.

Equities

LCTX

US53566P1093

Market Closed - Nyse
Other stock markets
 04:10:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
1.17 USD -0.85% Intraday chart for Lineage Cell Therapeutics, Inc. +10.38% +7.34%
May. 09 Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09 Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q1 Revenue $1.4M, vs. Street Est of $1.36M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LINEAGE CELL THERAPEUTICS, INC. Stock Lineage Cell Therapeutics, Inc.
 221M - - -
MODERNA, INC. Stock Moderna, Inc.
 44.96B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.65B
LONZA GROUP AG Stock Lonza Group AG
 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.08B
  1. Stock Market
  2. Equities
  3. LCTX Stock
  4. Charts Lineage Cell Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW